ECSP22012650A - Composiciones que comprenden tigolaner para el control de parásitos - Google Patents

Composiciones que comprenden tigolaner para el control de parásitos

Info

Publication number
ECSP22012650A
ECSP22012650A ECSENADI202212650A ECDI202212650A ECSP22012650A EC SP22012650 A ECSP22012650 A EC SP22012650A EC SENADI202212650 A ECSENADI202212650 A EC SENADI202212650A EC DI202212650 A ECDI202212650 A EC DI202212650A EC SP22012650 A ECSP22012650 A EC SP22012650A
Authority
EC
Ecuador
Prior art keywords
tigolaner
parasites
control
compositions
medicament
Prior art date
Application number
ECSENADI202212650A
Other languages
English (en)
Inventor
Kanikanti Venkata-Rangarao
Feldhues Elisabeth
Heep Iris
Siegel David
Petry Gabriele
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of ECSP22012650A publication Critical patent/ECSP22012650A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende tigolaner y, opcionalmente, agentes endoparasiticidas, un método para su fabricación y su uso como un medicamento para el control de parásitos.
ECSENADI202212650A 2019-08-14 2022-02-17 Composiciones que comprenden tigolaner para el control de parásitos ECSP22012650A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19191727 2019-08-14
PCT/EP2020/072640 WO2021028479A1 (en) 2019-08-14 2020-08-12 Compositions comprising tigolaner for controlling parasites

Publications (1)

Publication Number Publication Date
ECSP22012650A true ECSP22012650A (es) 2022-03-31

Family

ID=67658818

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202212650A ECSP22012650A (es) 2019-08-14 2022-02-17 Composiciones que comprenden tigolaner para el control de parásitos

Country Status (20)

Country Link
US (2) US12502390B2 (es)
EP (1) EP4013388A1 (es)
JP (1) JP7596359B2 (es)
KR (1) KR102930844B1 (es)
CN (2) CN114698369A (es)
AU (1) AU2020328863B2 (es)
BR (1) BR112022002623A2 (es)
CA (1) CA3147171A1 (es)
CO (1) CO2022002898A2 (es)
CR (1) CR20220112A (es)
DO (1) DOP2022000035A (es)
EC (1) ECSP22012650A (es)
IL (1) IL290597A (es)
MX (1) MX2022001764A (es)
PH (1) PH12022550328A1 (es)
TW (1) TWI861178B (es)
UA (1) UA128873C2 (es)
UY (1) UY38841A (es)
WO (1) WO2021028479A1 (es)
ZA (1) ZA202202672B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI861178B (zh) 2019-08-14 2024-11-11 法商維多奎諾公司 用於控制寄生蟲之組成物
PH12022553222A1 (en) 2020-05-29 2024-02-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105065A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
DK182016B1 (en) 2023-03-13 2025-05-28 Zoetis Services Llc Degradation of isoxazolines in ozonated sea water

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132199C (en) 1992-03-17 2000-01-18 Hitoshi Nishiyama Depsipeptide derivative, production thereof and use thereof
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
CN1662440A (zh) 2002-06-26 2005-08-31 打矢恒温器株式会社 氢制造方法和氢供给装置
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE102004020721A1 (de) 2004-04-28 2005-11-24 Bayer Healthcare Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006061538A1 (de) 2006-12-27 2008-07-03 Bayer Healthcare Ag Kombinationsprodukt zur Bekämpfung von Parasiten an Tieren
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
JP6148730B2 (ja) 2012-07-19 2017-06-14 バイエル・クロップサイエンス・アクチェンゲゼルシャフト ５−フルオロ−１ｈ−ピラゾール類の製造方法
JP6321042B2 (ja) * 2013-02-06 2018-05-09 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 新規なハロゲン置換された化合物
JP6613234B2 (ja) 2013-11-27 2019-11-27 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ５−フルオロ−１ｈ−ピラゾール類の調製のための方法
JP6678581B2 (ja) 2013-11-27 2020-04-08 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ ５−フルオロ−１ｈ−ピラゾール類の調製のための方法
JP2017509673A (ja) 2014-04-01 2017-04-06 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Ｎ−［３−（ベンジルカルバモイル）フェニル］−１ｈ−ピラゾール−５−カルボキサミドの製造方法
TWI694066B (zh) 2014-05-27 2020-05-21 德商拜耳動物保健有限公司 始於六氟丙烯之製備５-氟-１ｈ-吡唑的方法
JP6676038B2 (ja) 2014-08-19 2020-04-08 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ ヘキサフルオロプロペンから出発する５−フルオロ−１ｈ−ピラゾール類の調製のための方法
WO2016174049A1 (en) 2015-04-30 2016-11-03 Bayer Animal Health Gmbh Anti-parasitic combinations including halogen-substituted compounds
BR112017023662B1 (pt) 2015-05-05 2022-06-07 Syngenta Participations Ag Método de controle e/ou prevenção de infestação de percevejos, uso de um composto e método para cultivar soja
AR104691A1 (es) 2016-05-18 2017-08-09 Labyes De Uruguay S A Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros
AU2018329158A1 (en) * 2017-09-06 2020-03-05 Bayer Animal Health Gmbh Topically administrable formulation for the control and prevention of animal parasites
TWI791054B (zh) 2017-10-18 2023-02-01 德商拜耳廠股份有限公司 具有殺昆蟲/殺蟎性質之活性化合物組合（五）
JP2019094270A (ja) 2017-11-17 2019-06-20 日産化学株式会社 有害生物防除用組成物及び有害生物の防除方法
TWI861178B (zh) 2019-08-14 2024-11-11 法商維多奎諾公司 用於控制寄生蟲之組成物

Also Published As

Publication number Publication date
ZA202202672B (en) 2023-05-31
UY38841A (es) 2021-02-26
MX2022001764A (es) 2022-08-04
DOP2022000035A (es) 2022-05-31
US12502390B2 (en) 2025-12-23
CN120478592A (zh) 2025-08-15
US20220331314A1 (en) 2022-10-20
PH12022550328A1 (en) 2023-02-06
JP7596359B2 (ja) 2024-12-09
CO2022002898A2 (es) 2022-04-19
CN114698369A (zh) 2022-07-01
AU2020328863B2 (en) 2025-10-23
BR112022002623A2 (pt) 2022-05-03
KR20220054319A (ko) 2022-05-02
CR20220112A (es) 2022-06-21
NZ785805A (en) 2025-10-31
TWI861178B (zh) 2024-11-11
US20260007662A1 (en) 2026-01-08
UA128873C2 (uk) 2024-11-13
CA3147171A1 (en) 2021-02-18
KR102930844B1 (ko) 2026-02-26
IL290597A (en) 2022-04-01
TW202122079A (zh) 2021-06-16
EP4013388A1 (en) 2022-06-22
JP2022544537A (ja) 2022-10-19
WO2021028479A1 (en) 2021-02-18
AU2020328863A1 (en) 2022-04-07

Similar Documents

Publication Publication Date Title
CO2022002898A2 (es) Composiciones que comprenden tigolaner para el control de parásitos
CO2020012824A2 (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma
ECSP17007538A (es) 2-(morfolin-4-il)-1,7-naftiridinas
CL2020001394A1 (es) Combinación de un derivado de 4-pirimidinsulfamida con un inhibidor de sglt-2 para el tratamiento contra enfermedades relacionadas con endotelina.
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
CL2017002650A1 (es) Compuestos novedosos
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
ECSP16095381A (es) Difluorometil-indanil-carboxamidas nicotínicas
UY36730A (es) Fenoxifenilamidinas sustituidas con halógeno y el uso de estas como fungicidas
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
MX2019009606A (es) Bis-compuestos para dispositivos opticamente activos.
MX2019001121A (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion.
DOP2020000100A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
NI202000042A (es) Polimorfos
DOP2016000268A (es) Compuestos de azol amido–sustituidos como inhibidores de tnks1 y/o tnks2
MX2019014192A (es) Inhibidor de inmunosupresion asociado al cancer.
CL2017001981A1 (es) Composiciones pesticida y métodos para controlar plagas.
AR106221A1 (es) Una composición de toxicidad baja
BR112018003209A2 (pt) composição compreendendo uma lactama e um lactato de alquila ou alquenila
AR101736A1 (es) Composiciones que contienen zinc, con aceites esenciales
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MX2016009567A (es) Composicion antifungica.
MX2019007196A (es) Composiciones para el cuidado bucal.